Guardant Health Investor Presentation slide image

Guardant Health Investor Presentation

Introducing the LUNAR assay LUNAR now available for research use by biopharmaceutical and academic researchers Genomic Alterations Biological Noise Filter 80,000 GUARDANT 360 + Tests ctDNA Whole Genome Sequencing Epigenomic Signatures Pub Med LUNAR TEST RESULT + Signal Integration TCGAⒸ ctDNA present / absent Epigenomic Classifier Launched for RUO in Q4'18 and planned CLIA launch for prospective studies in 2H'19 21 GUARDANT
View entire presentation